NCT07226271 Consumer Perceptions of Alcoholic Beverages
| NCT ID | NCT07226271 |
| Status | Recruiting |
| Phase | — |
| Sponsor | UNC Lineberger Comprehensive Cancer Center |
| Condition | Health Behavior |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2025-10-10 |
| Primary Completion | 2026-09-17 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,500 participants in total. It began in 2025-10-10 with a primary completion date of 2026-09-17.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to examine the effects of marketing claims on alcoholic beverage packaging on alcohol consumers' perceptions and intentions. Participants will be randomized to view three images of alcoholic beverages (beer, hard seltzer, flavored malt beverage) with one of three marketing claims (or a no claim control), and then queried about their perceptions of the product and intentions to consume the product.
Eligibility Criteria
Inclusion Criteria: * Adults ages 21 years and older * Consumed alcohol at least once in the last year * Able to complete a survey in English Exclusion Criteria: \- Not living in the US
Contact & Investigator
Phoebe R Ruggles, MS
PRINCIPAL INVESTIGATOR
UNC-Chapel Hill
Frequently Asked Questions
Who can join the NCT07226271 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 99 Years, studying Health Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07226271 currently recruiting?
Yes, NCT07226271 is actively recruiting participants. Contact the research team at pruggles@unc.edu for enrollment information.
Where is the NCT07226271 trial being conducted?
This trial is being conducted at Chapel Hill, United States.
Who is sponsoring the NCT07226271 clinical trial?
NCT07226271 is sponsored by UNC Lineberger Comprehensive Cancer Center. The principal investigator is Phoebe R Ruggles, MS at UNC-Chapel Hill. The trial plans to enroll 1,500 participants.